K Number
K133911
Device Name
GENESYS SPINE ANTERIOR BUTTRESS PLATE SYSTEM
Manufacturer
Date Cleared
2014-09-03

(254 days)

Product Code
Regulation Number
888.3060
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Genesys Spine Anterior Buttress Plate system in conjunction with traditional rigid fixation is intended for use in spinal fusion procedures as a means to maintain the relative position of weak bony tissue such as allografts or autografts. This device is not intended for load bearing applications.
Device Description
The Genesys Spine Anterior Buttress Plate System will be offered in various device configurations based on surgical approach and patient anatomy, and will consist of a Genesys Spine buttress plate and screws that are inserted into the anterior surface of adjacent lumbar vertebrae.
More Information

Not Found

No
The 510(k) summary describes a mechanical spinal implant system and does not mention any AI or ML components or functionalities.

No
Therapeutic devices are generally defined as those that cure, treat, prevent, or diagnose a disease or condition. This device is described as maintaining the relative position of weak bony tissue, and while it assists in fusion (a treatment), it is considered a mechanical support for grafts rather than an active therapeutic agent itself.

No
The device is described as a "buttress plate system" used in spinal fusion procedures to maintain the relative position of weak bony tissue, not to diagnose a condition.

No

The device description explicitly states it consists of a buttress plate and screws, which are physical hardware components. The performance studies also involve mechanical testing of these physical components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the device is for use in spinal fusion procedures to maintain the relative position of bony tissue. This is a surgical implant used in vivo (within the body).
  • Device Description: The description details a plate and screws inserted into vertebrae, which are physical components used in surgery.
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue) in vitro (outside the body) to provide information about a physiological state, health, or disease.

IVD devices are used to perform tests on samples taken from the body, while this device is a surgical implant used directly on the patient's anatomy.

N/A

Intended Use / Indications for Use

The Genesys Spine Anterior Buttress Plate system in conjunction with traditional rigid fixation is intended for use in spinal fusion procedures as a means to maintain the relative position of weak bony tissue such as allografts. This device is not intended for load bearing applications.

Product codes

KWQ

Device Description

The Genesys Spine Anterior Buttress Plate System will be offered in various device configurations based on surgical approach and patient anatomy, and will consist of a Genesys Spine buttress plate and screws that are inserted into the anterior surface of adjacent lumbar vertebrae.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

adjacent lumbar vertebrae

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Prescription Use

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

The predetermined pass-fail criterion was that the mechanical test results for the Genesys Spine Anterior Buttress Plate System be equivalent to (or greater than) previously cleared anterior buttress plate systems. Prior to performing mechanical testing, all possible configurations of the Anterior Buttress Plate System construct were analyzed in order to determine the worst case to be used for testing. Static and dynamic cantilever bending testing in accordance with American Society for Testing and Materials (ASTM) F1717 "Standard Test Methods for Static and Fatigue for Spinal Implant Constructs in a Vertebrectomy Model" were then performed on the worst case Anterior Buttress Plate System construct.

Key Metrics

Not Found

Predicate Device(s)

K081770, K021039, K072943

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 888.3060 Spinal intervertebral body fixation orthosis.

(a)
Identification. A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.(b)
Classification. Class II.

0

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around it. Inside the circle is a stylized image of three human profiles facing right, with flowing lines connecting them.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

September 3, 2014

Genesys Spine Mr. Brian J. Bergeron Vice President of Engineering 1250 Capital of Texas Highway South Building Three, Suite 600 Austin, Texas 78746

Re: K133911

Trade/Device Name: Genesys Spine Anterior Buttress Plate System Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal intervertebral body fixation orthosis Regulatory Class: Class II Product Code: KWQ Dated: July 29, 2014 Received: August 5, 2014

Dear Mr. Bergeron:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

1

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Ronald#Aean -S for

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K133911

Device Name

Genesys Spine Anterior Buttress Plate System

Indications for Use (Describe)

The Genesys Spine Anterior Buttress Plate system in conjunction with traditional rigid fixation is intended for use in spinal fusion procedures as a means to maintain the relative position of weak bony tissue such as allografts. This device is not intended for load bearing applications.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

5. 510(K) SUMMARY

Submitter's Name:Genesys Spine
Submitter's Address:1250 Capital of Texas Highway South
Building Three, Suite 600
Austin, Texas 78746
Submitter's Telephone:512-381-7071
Submitter's Fax:512-381-7076
Contact Name:Brian J. Bergeron
Date Summary was
Prepared:July 29, 2014
Trade or Proprietary Name:Genesys Spine Anterior Buttress Plate System
Common or Usual Name:Spinal Intervertebral Body Fixation Orthosis
Classification:Class II per 21 CFR §888.3060
Product Codes:KWQ
Classification Panel:Orthopedic and Rehabilitation Devices Panel

DESCRIPTION OF THE DEVICE SUBJECT TO PREMARKET NOTIFICATION:

The Genesys Spine Anterior Buttress Plate System will be offered in various device configurations based on surgical approach and patient anatomy, and will consist of a Genesys Spine buttress plate and screws that are inserted into the anterior surface of adjacent lumbar vertebrae.

Indications for Use

The Genesys Spine Anterior Buttress Plate system in conjunction with traditional rigid fixation is intended for use in spinal fusion procedures as a means to maintain the relative position of weak bony tissue such as allografts or autografts. This device is not intended for load bearing applications.

4

TECHNICAL CHARACTERISTICS

The Genesys Spine Anterior Buttress Plate System is comprised of multiple sizes of plates and screws that are inserted into the anterior surface of adjacent lumbar vertebrae. The device is applied after discectomy and insertion of autograft or allograft in the interbody space, and acts to stabilize the spine during fusion.

The plate components are manufactured from medical grade Ti-6Al-4V ELI titanium alloy per ASTM F-136. Additionally, plates contain a securement tab component comprised of medical grade Ti-6Al-4V ELI titanium alloy per ASTM F-136 to ensure that the screw is locked in place. The bone screws are manufactured from medical grade Ti-6Al-4V ELI titanium alloy per ASTM F-136.

PERFORMANCE DATA

The predetermined pass-fail criterion was that the mechanical test results for the Genesys Spine Anterior Buttress Plate System be equivalent to (or greater than) previously cleared anterior buttress plate systems. Prior to performing mechanical testing, all possible configurations of the Anterior Buttress Plate System construct were analyzed in order to determine the worst case to be used for testing. Static and dynamic cantilever bending testing in accordance with American Society for Testing and Materials (ASTM) F1717 "Standard Test Methods for Static and Fatigue for Spinal Implant Constructs in a Vertebrectomy Model" were then performed on the worst case Anterior Buttress Plate System construct.

CONCLUSION

The overall technological characteristics and mechanical performance data lead to the conclusion that the Genesys Spine Anterior Buttress Plate System is substantially equivalent to the Black Widow Anterior Buttress Plate (Omni Spine - K081770), BOWTI Anterior Buttress Staple System (Depuy Acromed - K021039), and Butrex Buttress Plating System (X-Spine, Inc. -K072943).